Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Confronting the scientific obstacles to global control of tuberculosis
Douglas B. Young, … , Ken Duncan, Clifton E. Barry III
Douglas B. Young, … , Ken Duncan, Clifton E. Barry III
Published April 1, 2008
Citation Information: J Clin Invest. 2008;118(4):1255-1265. https://doi.org/10.1172/JCI34614.
View: Text | PDF
Review Series Article has an altmetric score of 10

Confronting the scientific obstacles to global control of tuberculosis

  • Text
  • PDF
Abstract

Tuberculosis (TB) is a major threat to global health, recently exacerbated by the emergence of highly drug-resistant forms of the disease-causing pathogen and synergy with HIV/AIDS. In 2006, the Stop TB Partnership published “The global plan to stop TB: 2006–2015,” which set out a vision of halving the prevalence of and mortality caused by the disease by 2015, followed by eliminating the disease as a public health problem by 2050. This vision depends on the development of improved diagnostics, simpler treatment, and more effective vaccination. Recently, active translational research pipelines directed toward each of these goals have been established, but improved understanding of the fundamental biology of this complex disease will prove to be the key to radical advances in TB control.

Authors

Douglas B. Young, Mark D. Perkins, Ken Duncan, Clifton E. Barry III

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 Total
Citations: 2 1 2 2 6 1 3 5 5 7 8 6 12 12 13 12 20 4 121
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (121)

Title and authors Publication Year
Explore the Application Value of Metagenomic Next-Generation Sequencing of Bronchoalveolar Lavage Fluid in the Early Diagnosis of Pulmonary Tuberculosis
Lu Y, Zhang C, Wu J, Xu X, Lu A, Huang H, Chen M
Infection and Drug Resistance 2025
Deciphering the Correlation between the Emergence of Lung Carcinoma Associated with Tuberculosis-related Inflammation.
Chauhan P, Pandey P, Ramniwas S, Khan F, Maqsood R
Endocrine, metabolic & immune disorders drug targets 2025
A virulence-associated small RNA MTS1338 activates an ABC transporter CydC for rifampicin efflux in Mycobacterium tuberculosis.
Singh S, Dutta T
Frontiers in microbiology 2024
Optimized LC-MS/MS quantification of tuberculosis drug candidate macozinone (PBTZ169), its dearomatized Meisenheimer Complex and other metabolites, in human plasma and urine
Desfontaine V, Guinchard S, Marques S, Vocat A, Moulfi F, Versace F, Huser-Pitteloud J, Ivanyuk A, Bardinet C, Makarov V, Ryabova O, André P, Prod'Hom S, Chtioui H, Buclin T, Cole ST, Decosterd L
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2023
A Comparative Analysis of Microscopy, Culture, and the Xpert Mycobacterium tuberculosis/Rifampicin Assay in Diagnosing Pulmonary Tuberculosis in Human Immunodeficiency-Positive Individuals
Kumar M, Kumar G, Kumar R, Muni S, Choubey S, Kumar S, Kumari N
Cureus 2023
Next-Generation Metagenome Sequencing Shows Superior Diagnostic Performance in Acid-Fast Staining Sputum Smear-Negative Pulmonary Tuberculosis and Non-tuberculous Mycobacterial Pulmonary Disease.
Xu P, Yang K, Yang L, Wang Z, Jin F, Wang Y, Feng J
Frontiers in microbiology 2022
Heterologous prime-boost BCG with DNA vaccine expressing fusion antigens Rv2299c and Ag85A improves protective efficacy against Mycobacterium tuberculosis in mice.
Wu J, Hu Z, Lu SH, Fan XY
Frontiers in microbiology 2022
Comparative Performance of Line Probe Assay (Version 2) and Xpert MTB/RIF Assay for Early Diagnosis of Rifampicin-Resistant Pulmonary Tuberculosis
RN Yadav, BK Singh, R Sharma, J Chaubey, S Sinha, P Jorwal
Tuberculosis and Respiratory Diseases 2021
HLA-DR-Positive NK Cells Expand in Response to Mycobacterium Tuberculosis Antigens and Mediate Mycobacteria-Induced T Cell Activation
SA Kust, MA Streltsova, AV Panteleev, NL Karpina, IV Lyadova, AM Sapozhnikov, EI Kovalenko
Frontiers in immunology 2021
Intracellular localisation of Mycobacterium tuberculosis affects efficacy of the antibiotic pyrazinamide
P Santucci, DJ Greenwood, A Fearns, K Chen, H Jiang, MG Gutierrez
Nature Communications 2021
Intracellular Accumulation of Novel and Clinically Used TB Drugs Potentiates Intracellular Synergy
L Tanner, GT Mashabela, CC Omollo, TJ de Wet, CJ Parkinson, DF Warner, RK Haynes, L Wiesner, PC Karakousis
Microbiology spectrum 2021
Pulling the Brakes on Fast and Furious Multiple Drug-Resistant (MDR) Bacteria
A Khan, K Manzoor, A Sultan, M Saeed, M Rafique, S Noushad, A Talib, S Rentschler, HP Deigner
International journal of molecular sciences 2021
Association of High-Speed Rail and Tuberculosis Transmission in Newly Integrated Regions: Quasi-Experimental Evidence from China
Y Liu, C Tang, T Bu, D Tang
International Journal of Public Health 2021
Prevalence of latent tuberculosis infection and associated risk factors in prison in East Wollega Zone of western Ethiopia
B Chekesa, B Gumi, M Chanyalew, A Zewude, G Ameni, HS Ehtesham
PloS one 2020
Mycobacterium tuberculosis infection of host cells in space and time
C Bussi, MG Gutierrez
FEMS Microbiology Reviews 2019
Cell wall peptidoglycan in Mycobacterium tuberculosis: An Achilles’ heel for the TB-causing pathogen
A Maitra, T Munshi, J Healy, LT Martin, W Vollmer, NH Keep, S Bhakta
FEMS Microbiology Reviews 2019
Phenazine Antibiotic‐Inspired Discovery of Bacterial Biofilm‐Eradicating Agents
RW Huigens, Y Abouelhassan, H Yang
Chembiochem : a European journal of chemical biology 2019
Ultrasound Assisted Synthesis of 4-(Benzyloxy)-N-(3-chloro-2-(substitutedphenyl)-4-oxoazetidin-1-yl) Benzamide as Challenging Anti-Tubercular Scaffold
U Nimbalkar, J Seijas, R Borkute, M Damale, J Sangshetti, D Sarkar, A Nikalje
Molecules (Basel, Switzerland) 2018
Latent tuberculosis infection and associated risk indicators in pastoral communities in southern Ethiopia: a community based cross-sectional study
T Teklu, M Legesse, G Medhin, A Zewude, M Chanyalew, M Zewdie, B Wondale, M Haile-Mariam, R Pieper, G Ameni
BMC Public Health 2018
Antimycobacterial, Enzyme Inhibition, and Molecular Interaction Studies of Psoromic Acid in Mycobacterium tuberculosis: Efficacy and Safety Investigations
S Hassan, M Šudomová, K Berchová-Bímová, S Gowrishankar, K Rengasamy
Journal of Clinical Medicine 2018
Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine
N Gupta, S Garg, S Vedi, DY Kunimoto, R Kumar, B Agrawal
Frontiers in immunology 2018
Structures of DPAGT1 Explain Glycosylation Disease Mechanisms and Advance TB Antibiotic Design
YY Dong, H Wang, AC Pike, SA Cochrane, S Hamedzadeh, FJ Wyszyński, SR Bushell, SF Royer, DA Widdick, A Sajid, HI Boshoff, Y Park, R Lucas, WM Liu, SS Lee, T Machida, L Minall, S Mehmood, K Belaya, WW Liu, A Chu, L Shrestha, SM Mukhopadhyay, C Strain-Damerell, R Chalk, NA Burgess-Brown, MJ Bibb, CE Barry, CV Robinson, D Beeson, BG Davis, EP Carpenter
Cell 2018
Mycobacterium tuberculosis replicates within necrotic human macrophages
TR Lerner, S Borel, DJ Greenwood, U Repnik, MR Russell, S Herbst, ML Jones, LM Collinson, G Griffiths, MG Gutierrez
The Journal of Cell Biology 2017
Pharmacokinetic-Pharmacodynamic modelling of intracellular Mycobacterium tuberculosis growth and kill rates is predictive of clinical treatment duration
G Aljayyoussi, VA Jenkins, R Sharma, A Ardrey, S Donnellan, SA Ward, GA Biagini
Scientific Reports 2017
A Highly Potent Class of Halogenated Phenazine Antibacterial and Biofilm-Eradicating Agents Accessed Through a Modular Wohl-Aue Synthesis
H Yang, Y Abouelhassan, GM Burch, D Kallifidas, G Huang, H Yousaf, S Jin, H Luesch, RW Huigens
Scientific Reports 2017
Clinical and genomic responses to ultra-short course chemotherapy in spinal tuberculosis
N Niu, Q Wang, J Shi, X Zhang, G Geng, S Zhou, C Thach, F Cheng, Z Wang
Experimental and therapeutic medicine 2017
Childhood tuberculosis is associated with decreased abundance of T cell gene transcripts and impaired T cell function
C Hemingway, M Berk, ST Anderson, VJ Wright, S Hamilton, H Eleftherohorinou, M Kaforou, GM Goldgof, K Hickman, B Kampmann, J Schoeman, B Eley, D Beatty, S Pienaar, MP Nicol, MJ Griffiths, SJ Waddell, SM Newton, LJ Coin, DA Relman, G Montana, M Levin, ME Rottenberg
PloS one 2017
Rapid Diagnosis of Tuberculosis from Analysis of Urine Volatile Organic Compounds
SH Lim, R Martino, V Anikst, Z Xu, S Mix, R Benjamin, H Schub, M Eiden, PA Rhodes, N Banaei
ACS Sensors 2016
Insufficient Generation of Mycobactericidal Mediators and Inadequate Level of Phagosomal Maturation Are Related with Susceptibility to Virulent Mycobacterium tuberculosis Infection in Mouse Macrophages
HJ Lee, HJ Ko, YJ Jung
Frontiers in microbiology 2016
Genetic polymorphisms of IL-17A, IL-17F, TLR4 and miR-146a in association with the risk of pulmonary tuberculosis
M Wang, G Xu, L Lü, K Xu, Y Chen, H Pan, B Burstrom, K Burstrom, J Wang
Scientific Reports 2016
The GenePOC Platform, a Rational Solution for Extreme Point-of-Care Testing
L Bissonnette, M Bergeron
MICROMACHINES-BASEL 2016
Adult pulmonary tuberculosis as a pathological manifestation of hyperactive antimycobacterial immune response
P Kumar
Clinical and Translational Medicine 2016
The reliability analysis of Xpert-positive result for smear-negative and culture-negative specimen collected from bone and joint tuberculosis suspects
G Wei, J Mu, G Wang, F Huo, L Dong, Y Li, H Huang
Journal of Thoracic Disease 2016
Bedaquiline versus placebo for management of multiple drug-resistant tuberculosis: A systematic review
J Charan, T Reljic, A Kumar
Indian journal of pharmacology 2016
Monosodium Urate Crystals Promote Innate Anti-Mycobacterial Immunity and Improve BCG Efficacy as a Vaccine against Tuberculosis
F Taus, MB Santucci, E Greco, M Morandi, I Palucci, S Mariotti, N Poerio, R Nisini, G Delogu, M Fraziano, TJ Scriba
PloS one 2015
Co-evolution of Mycobacterium tuberculosis and Homo sapiens
D Brites, S Gagneux
Immunological Reviews 2015
The Application of GeneXpert MTB/RIF for Smear-Negative TB Diagnosis as a Fee-Paying Service at a South Asian General Hospital
P Shrestha, A Arjyal, M Caws, KG Prajapati, A Karkey, S Dongol, S Pathak, S Prajapati, B Basnyat
Tuberculosis Research and Treatment 2015
Protective capacity of proteoliposomes from Mycobacterium bovis BCG in a mouse model of tuberculosis
Y Tirado, A Puig, N Alvarez, R Borrero, A Aguilar, F Camacho, F Reyes, S Fernández, JL Pérez, DM Espinoza, JA Payán, ME Sarmiento, MN Norazmi, R Hernández-Pando, A Acosta
Human Vaccines & Immunotherapeutics 2015
Factors affecting mortality and treatment completion of tuberculosis patients in Isfahan Province from 2006 to 2011
M Shahrezaei, MR Maracy, F Farid
International journal of preventive medicine 2015
Impact of Educational Intervention on Patients Behavior with Smear-positive Pulmonary Tuberculosis: A Study Using the Health Belief Model
K Jadgal, T NakhaeiMoghadam, H AlizadehSeiouki, I Zareban, J SharifiRad
Materia socio-medica 2015
Synchronous Oral Paracoccidioidomycosis and Pulmonary Tuberculosis in an Immunocompetent Patient
AC Pellicioli, R Neves-Silva, AR Santos-Silva, PA Vargas, MA Lopes
Mycopathologia 2015
Natural Killer Cells: A Coherent Model for Their Functional Role in Mycobacterium tuberculosis Infection
S Esin, G Batoni
Journal of Innate Immunity 2015
A Toolbox for Tuberculosis (TB) Diagnosis: An Indian Multi-Centric Study (2006-2008); Evaluation of Serological Assays Based on PGL-Tb1 and ESAT-6/CFP10 Antigens for TB Diagnosis
PH Lagrange, SK Thangaraj, R Dayal, A Deshpande, NK Ganguly, E Girardi, B Joshi, K Katoch, VM Katoch, M Kumar, V Lakshmi, M Leportier, C Longuet, SV Malladi, D Mukerjee, D Nair, A Raja, B Raman, C Rodrigues, P Sharma, A Singh, S Singh, A Sodha, BS Kabeer, G Vernet, D Goletti
PloS one 2014
In Silico Studies of Quinoxaline-2-Carboxamide 1,4-di-N-Oxide Derivatives as Antimycobacterial Agents
A Radwan, W Abdel-Mageed
Molecules (Basel, Switzerland) 2014
Optimising Mycobacterium tuberculosis detection in resource limited settings
N Alfred, L Lovette, G Aliyu, O Olusegun, P Meshak, T Jilang, M Iwakun, E Nnamdi, O Olubunmi, P Dakum, A Abimiku
BMJ Open 2014
Pathogen-derived biomarkers for active tuberculosis diagnosis
P Tucci, G González-Sapienza, M Marin
Frontiers in microbiology 2014
Factors related to adopting healthy behaviors by patients with tuberculosis in Isfahan: Application of health belief model
Maryam Johari, Ahmad Ali Eslami, Hamid Alahverdipoor, Akbar Hasanzade, Fariba Farid
Journal of Education and Health Promotion 2014
Exploration of Novel Cellular and Serological Antigen Biomarkers in the ORFeome of Mycobacterium tuberculosis
L Liu, W Zhang, J Zheng, H Fu, Q Chen, Z Zhang, X Chen, B Zhou, L Feng, H Liu, Q Jin
Molecular & cellular proteomics : MCP 2014
The Prevalence of Tb in HIV Patients and Risk Factor With Frequent Referral (Iran, 2009-10)
N Rabirad, EM Nejad, MR Hadizadeh, J Begjan, SR Ehsani
Iranian Red Crescent Medical Journal 2013
Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32
SA Stanley, T Kawate, N Iwase, M Shimizu, AE Clatworthy, E Kazyanskaya, JC Sacchettini, TR Ioerger, NA Siddiqi, S Minami, JA Aquadro, SS Grant, EJ Rubin, DT Hung
Proceedings of the National Academy of Sciences 2013
Identification of 1-[(4-Benzyloxyphenyl)-but-3-enyl]-1H-azoles as New Class of Antitubercular and Antimicrobial Agents
N Anand, KK Ramkrishna, MP Gupt, V Chaturvedi, S Singh, KK Srivastava, P Sharma, N Rai, R RAMACHANDRAN, AK Dwivedi, V Gupta, B Kumar, S Pandey, PK Shukla, SK Pandey, J Lal, RP Tripathi
ACS Medicinal Chemistry Letters 2013
Increased production of IL-4 and IL-12p40 from bronchoalveolar lavage cells are biomarkers of Mycobacterium tuberculosis in the sputum
A Nolan, E Fajardo, ML Huie, R Condos, A Pooran, R Dawson, K Dheda, E Bateman, WN Rom, MD Weiden
PloS one 2013
A genetic strategy to identify targets for the development of drugs that prevent bacterial persistence
JH Kim, KM O'Brien, R Sharma, HI Boshoff, G Rehren, S Chakraborty, JB Wallach, M Monteleone, DJ Wilson, CC Aldrich, CE Barry, KY Rhee, S Ehrt, D Schnappinger
Proceedings of the National Academy of Sciences 2013
A novel recombinant DNA vaccine encoding Mycobacterium tuberculosis ESAT-6 and FL protects against Mycobacterium tuberculosis challenge in mice
Q Jiang, J Zhang, X Chen, M Xia, Y Lu, W Qiu, G Feng, D Zhao, Y Li, F He, G Peng, Y Wang
Journal of Biomedical Research 2013
Application of hyperbranched rolling circle amplification for direct detection of mycobacterium tuberculosis in clinical sputum specimens
Y Liu, YL Guo, GL Jiang, SJ Zhou, Q Sun, X Chen, XJ Chang, AY Xing, FJ Du, HY Jia, ZD Zhang
PloS one 2013
Effects of gender and age on development of concurrent extrapulmonary tuberculosis in patients with pulmonary tuberculosis: a population based study
CY Lin, TC Chen, PL Lu, CC Lai, YH Yang, WR Lin, PM Huang, YH Chen
PloS one 2013
Screening for pulmonary tuberculosis in HIV-infected individuals: AIDS Clinical Trials Group Protocol A5253
S Swindells, L Komarow, S Tripathy, KP Cain, RR MacGregor, JM Achkar, A Gupta, VG Veloso, A Asmelash, AE Omoz-Oarhe, S Gengiah, U Lalloo, R Allen, C Shiboski, J Andersen, SS Qasba, DK Katzenstein,
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2013
Immunogenicity of recombinant Mycobacterium bovis bacille Calmette-Guèrin clones expressing T and B cell epitopes of Mycobacterium tuberculosis antigens
R Mohamud, M Azlan, D Yero, N Alvarez, ME Sarmiento, A Acosta, MN Norazmi
BMC Immunology 2013
Sputum microbiota in tuberculosis as revealed by 16S rRNA pyrosequencing
MK Cheung, WY Lam, WY Fung, PT Law, CH Au, W Nong, KM Kam, HS Kwan, SK Tsui
PloS one 2013
In silico identification of common epitopes from pathogenic mycobacteria
B de la Caridad Addine Ramírez, R Marrón, R Calero, M Mirabal, JC Ramírez, ME Sarmiento, MN Norazmi, A Acosta
BMC Immunology 2013
Translating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosis: Translational advances for MDR/XDR-TB
ND Walter, M Strong, R Belknap, DJ Ordway, CL Daley, ED Chan
Respirology 2012
Host–pathogen coevolution in human tuberculosis
S Gagneux
Philosophical Transactions of the Royal Society B: Biological Sciences 2012
A High-Throughput Screen To Identify Inhibitors of ATP Homeostasis in Non-replicating Mycobacterium tuberculosis
PA Mak, SP Rao, MP Tan, X Lin, J Chyba, J Tay, SH Ng, BH Tan, J Cherian, J Duraiswamy, P Bifani, V Lim, BH Lee, NL Ma, D Beer, P Thayalan, K Kuhen, A Chatterjee, F Supek, R Glynne, J Zheng, HI Boshoff, CE 3rd, T Dick, K Pethe, LR Camacho
ACS chemical biology 2012
New drugs to treat tuberculosis
S Swindells
F1000 medicine reports 2012
Rapid identification of Mycobacterium tuberculosis infection by a new array format-based surface plasmon resonance method
SC Hsieh, CC Chang, CC Lu, CF Wei, CS Lin, HC Lai, CW Lin
Nanoscale research letters 2012
The role of Ca2+ in the activity of Mycobacterium tuberculosis DNA gyrase
S Karkare, F Yousafzai, LA Mitchenall, A Maxwell
Nucleic Acids Research 2012
Monocyte-derived macrophages do not explain susceptibility to pulmonary non-tuberculous mycobacterial disease
E Jong, A Lim, G Waterer, P Price
IBMS BoneKEy 2012
Ultra-short-course chemotherapy for spinal tuberculosis: five years of observation
Z Wang, J Shi, G Geng, H Qiu
European Spine Journal 2012
The naphthoquinone diospyrin is an inhibitor of DNA gyrase with a novel mechanism of action
S Karkare, TT Chung, F Collin, LA Mitchenall, AR McKay, SJ Greive, JJ Meyer, N Lall, A Maxwell
The Journal of biological chemistry 2012
Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy
CI Bloom, CM Graham, MP Berry, KA Wilkinson, T Oni, F Rozakeas, Z Xu, J Rossello-Urgell, D Chaussabel, J Banchereau, V Pascual, M Lipman, RJ Wilkinson, A O'Garra
PloS one 2012
Mycobacterium tuberculosis CwsA interacts with CrgA and Wag31, and the CrgA-CwsA complex is involved in peptidoglycan synthesis and cell shape determination
P Plocinski, N Arora, K Sarva, E Blaszczyk, H Qin, N Das, R Plocinska, M Ziolkiewicz, J Dziadek, M Kiran, P Gorla, TA Cross, M Madiraju, M Rajagopalan
Journal of bacteriology 2012
Blockade of IL-10 Signaling during Bacillus Calmette-Guérin Vaccination Enhances and Sustains Th1, Th17, and Innate Lymphoid IFN-γ and IL-17 Responses and Increases Protection to Mycobacterium tuberculosis Infection
JM Pitt, E Stavropoulos, PS Redford, AM Beebe, GJ Bancroft, DB Young, A OGarra
Journal of immunology (Baltimore, Md. : 1950) 2012
VapC toxins from Mycobacterium tuberculosis are ribonucleases that differentially inhibit growth and are neutralized by cognate VapB antitoxins
BA Ahidjo, D Kuhnert, JL McKenzie, EE Machowski, BG Gordhan, V Arcus, GL Abrahams, V Mizrahi
PloS one 2011
Uptake of unnatural trehalose analogs as a reporter for Mycobacterium tuberculosis
KM Backus, HI Boshoff, CS Barry, O Boutureira, MK Patel, F D'Hooge, SS Lee, LE Via, K Tahlan, CE 3rd, BG Davis
Nature Chemical Biology 2011
A role for systems epidemiology in tuberculosis research
I Comas, S Gagneux
Trends in Microbiology 2011
Nitroimidazoles for the treatment of TB: past, present and future
T Mukherjee, H Boshoff
Future Medicinal Chemistry 2011
Reagent Precoated Targets for Rapid In-Tissue Derivatization of the Anti-Tuberculosis Drug Isoniazid Followed by MALDI Imaging Mass Spectrometry
ML Manier, ML Reyzer, A Goh, V Dartois, LE Via, CE 3rd, RM Caprioli
Journal of the American Society for Mass Spectrometry 2011
Fine mapping of genetic polymorphisms of pulmonary tuberculosis within chromosome 18q11.2 in the Chinese population: a case-control study
Y Dai, X Zhang, H Pan, S Tang, H Shen, J Wang
BMC Infectious Diseases 2011
Discovery of Novel MDR-Mycobacterium tuberculosis Inhibitor by New FRIGATE Computational Screen
C Scheich, Z Szabadka, B Vértessy, V Pütter, V Grolmusz, M Schade
PloS one 2011
Evaluation of Tuberculosis Diagnostics: Establishing an Evidence Base Around the Public Health Impact
RJ Lessells, GS Cooke, ML Newell, P Godfrey-Faussett
The Journal of Infectious Diseases 2011
Polymorphisms in Isoniazid and Prothionamide Resistance Genes of the Mycobacterium tuberculosis Complex▿
M Projahn, CU Köser, S Homolka, DK Summers, JA Archer, S Niemann
Antimicrobial agents and chemotherapy 2011
Evaluation of NTF1836 as an inhibitor of the mycothiol biosynthetic enzyme MshC in growing and non-replicating Mycobacterium tuberculosis
GL Newton, N Buchmeier, JJ la Clair, RC Fahey
Bioorganic & Medicinal Chemistry 2011
Substrate specificity of the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis responsible for the bioreductive activation of bicyclic nitroimidazoles
M Gurumurthy, T Mukherjee, CS Dowd, R Singh, P Niyomrattanakit, JA Tay, A Nayyar, YS Lee, J Cherian, HI Boshoff, T Dick, CE 3rd, UH Manjunatha
The FEBS journal 2011
A Novel Human IgA Monoclonal Antibody Protects against Tuberculosis
S Balu, R Reljic, MJ Lewis, RJ Pleass, R McIntosh, C van Kooten, M van Egmond, S Challacombe, JM Woof, J Ivanyi
Journal of immunology (Baltimore, Md. : 1950) 2011
Mutations in gidB Confer Low-Level Streptomycin Resistance in Mycobacterium tuberculosis
SY Wong, JS Lee, HK Kwak, LE Via, HI Boshoff, CE Barry
Antimicrobial agents and chemotherapy 2011
Serine protease activity contributes to control of tuberculosis in hypoxic granulomas in mice
Stephen T. Reece, Christoph Loddenkemper, David Askew, Ulrike Zedler, Sandra Schommer-Leitner, Maik Stein, Fayaz Ahmed Mir, Anca Dorhoi, Hans-Joachim Mollenkopf, Gary Silverman, Stefan Kaufmann
Journal of Clinical Investigation 2010
Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved
I Comas, J Chakravartti, PM Small, J Galagan, S Niemann, K Kremer, JD Ernst, S Gagneux
Nature Genetics 2010
Mycobacterium tuberculosis persistence mutants identified by screening in isoniazid-treated mice
N Dhar, JD McKinney
Proceedings of the National Academy of Sciences 2010
Nanobead-based interventions for the treatment and prevention of tuberculosis
G Griffiths, B Nyström, SB Sable, GK Khuller
Nature Reviews Microbiology 2010
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
MP Berry, CM Graham, FW McNab, Z Xu, SA Bloch, T Oni, KA Wilkinson, R Banchereau, J Skinner, RJ Wilkinson, C Quinn, D Blankenship, R Dhawan, JJ Cush, A Mejias, O Ramilo, OM Kon, V Pascual, J Banchereau, D Chaussabel, A O’Garra
Nature 2010
A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy
K Pethe, PC Sequeira, S Agarwalla, K Rhee, K Kuhen, WY Phong, V Patel, D Beer, JR Walker, J Duraiswamy, J Jiricek, TH Keller, A Chatterjee, MP Tan, M Ujjini, SP Rao, L Camacho, P Bifani, PA Mak, I Ma, SW Barnes, Z Chen, D Plouffe, P Thayalan, SH Ng, M Au, BH Lee, BH Tan, S Ravindran, M Nanjundappa, X Lin, A Goh, SB Lakshminarayana, C Shoen, M Cynamon, B Kreiswirth, V Dartois, EC Peters, R Glynne, S Brenner, T Dick
Nature Communications 2010
Association of genetic polymorphisms in the IL12-IFNG pathway with susceptibility to and prognosis of pulmonary tuberculosis in a Chinese population
J Wang, S Tang, H Shen
European Journal of Clinical Microbiology & Infectious Diseases 2010
Development and analysis of an in vivo-compatible metabolic network of Mycobacterium tuberculosis
X Fang, A Wallqvist, J Reifman
BMC Systems Biology 2010
Epidemiology and Challenges to the Elimination of Global Tuberculosis
MS Jassal, WR Bishai
Clinical Infectious Diseases 2010
Evaluation of the Analytical Performance of the Xpert MTB/RIF Assay
R Blakemore, E Story, D Helb, JA Kop, P Banada, MR Owens, S Chakravorty, M Jones, D Alland
Journal of clinical microbiology 2010
Comparison of the Moonlighting Actions of the Two Highly Homologous Chaperonin 60 Proteins of Mycobacterium tuberculosis
A Cehovin, AR Coates, Y Hu, Y Riffo-Vasquez, P Tormay, C Botanch, F Altare, B Henderson
Infection and immunity 2010
Microscopic Cords, a Virulence-Related Characteristic of Mycobacterium tuberculosis , Are Also Present in Nonpathogenic Mycobacteria
E Julián, M Roldán, A Sánchez-Chardi, O Astola, G Agustí, M Luquin
Journal of bacteriology 2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Cell-Mediated Immune Responses in Tuberculosis
AM Cooper
Annual Review of Immunology 2009
Incorporation of NKT Cell-Activating Glycolipids Enhances Immunogenicity and Vaccine Efficacy of Mycobacterium bovis Bacillus Calmette-Guérin
MM Venkataswamy, A Baena, MF Goldberg, G Bricard, JS Im, J Chan, F Reddington, GS Besra, WR Jacobs, SA Porcelli
Journal of immunology (Baltimore, Md. : 1950) 2009
Immunomodulation with recombinant interferon-gamma1b in pulmonary tuberculosis
R Dawson, R Condos, D Tse, ML Huie, S Ress, CH Tseng, C Brauns, M Weiden, Y Hoshino, E Bateman, WN Rom
PloS one 2009
Early Pulmonary Cytokine and Chemokine Responses in Mice Immunized with Three Different Vaccines against Mycobacterium tuberculosis Determined by PCR Array
JH Lim, SC Derrick, K Kolibab, AL Yang, S Porcelli, WR Jacobs, SL Morris
Clinical and vaccine immunology : CVI 2009
Vitamin D Deficiency and Its Health Consequences in Africa
A Prentice, I Schoenmakers, KS Jones, LM Jarjou, GR Goldberg
Clinical Reviews in Bone and Mineral Metabolism 2009
Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB
SY Eum, JH Kong, MS Hong, YJ Lee, JH Kim, SH Hwang, SN Cho, LE Via, CE 3rd
Chest 2009
IFNgamma response to Mycobacterium tuberculosis, risk of infection and disease in household contacts of tuberculosis patients in Colombia
H Corral, SC París, ND Marín, DM Marín, L López, HM Henao, T Martínez, L Villa, LF Barrera, BL Ortiz, ME Ramírez, CJ Montes, MC Oquendo, LM Arango, F Riaño, C Aguirre, A Bustamante, JT Belisle, K Dobos, GI Mejía, MR Giraldo, PJ Brennan, J Robledo, MP Arbeláez, CA Rojas, LF García
PloS one 2009
High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors
T Christophe, M Jackson, HK Jeon, D Fenistein, M Contreras-Dominguez, J Kim, A Genovesio, JP Carralot, F Ewann, EH Kim, SY Lee, S Kang, MJ Seo, EJ Park, H Skovierová, H Pham, G Riccardi, JY Nam, L Marsollier, M Kempf, ML Joly-Guillou, T Oh, WK Shin, Z No, U Nehrbass, R Brosch, ST Cole, P Brodin
PLoS pathogens 2009
The past and future of tuberculosis research
I Comas, S Gagneux
PLoS pathogens 2009
A systems biology framework for modeling metabolic enzyme inhibition of Mycobacterium tuberculosis
X Fang, A Wallqvist, J Reifman
BMC Systems Biology 2009
A novel recombinant human lactoferrin augments the BCG vaccine and protects alveolar integrity upon infection with Mycobacterium tuberculosis in mice
SA Hwang, K Wilk, ML Kruzel, JK Actor
Vaccine 2009
Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial
MB Conde, A Efron, C Loredo, GR de Souza, NP Graça, MC Cezar, M Ram, MA Chaudhary, WR Bishai, AL Kritski, RE Chaisson
Lancet 2009
Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis
V Makarov, G Manina, K Mikusova, U Möllmann, O Ryabova, B Saint-Joanis, N Dhar, MR Pasca, S Buroni, AP Lucarelli, A Milano, ED Rossi, M Belanova, A Bobovska, P Dianiskova, J Kordulakova, C Sala, E Fullam, P Schneider, JD McKinney, P Brodin, T Christophe, S Waddell, P Butcher, J Albrethsen, I Rosenkrands, R Brosch, V Nandi, S Bharath, S Gaonkar, RK Shandil, V Balasubramanian, T Balganesh, S Tyagi, J Grosset, G Riccardi, ST Cole
Science (New York, N.Y.) 2009
Clifton E. Barry, III: TB's strategic opponent. Interviewed by Amy Maxmen
CE Barry
Journal of Experimental Medicine 2009
TB database: an integrated platform for tuberculosis research
TB Reddy, R Riley, F Wymore, P Montgomery, D DeCaprio, R Engels, M Gellesch, J Hubble, D Jen, H Jin, M Koehrsen, L Larson, M Mao, M Nitzberg, P Sisk, C Stolte, B Weiner, J White, ZK Zachariah, G Sherlock, JE Galagan, CA Ball, GK Schoolnik
Nucleic Acids Research 2009
A novel DNA vaccine containing multiple TB-specific epitopes casted in a natural structure (ECANS) confers protective immunity against pulmonary mycobacterial challenge
H Gao, Y Yue, L Hu, W Xu, S Xiong
Vaccine 2009
Performance of Purified Antigens for Serodiagnosis of Pulmonary Tuberculosis: a Meta-Analysis
KR Steingart, N Dendukuri, M Henry, I Schiller, P Nahid, PC Hopewell, A Ramsay, M Pai, S Laal
Clinical and vaccine immunology : CVI 2009
BacA, an ABC Transporter Involved in Maintenance of Chronic Murine Infections with Mycobacterium tuberculosis
P Domenech, H Kobayashi, K LeVier, GC Walker, CE Barry
Journal of bacteriology 2009
Function and Regulation of Class I Ribonucleotide Reductase-Encoding Genes in Mycobacteria
MB Mowa, DF Warner, G Kaplan, BD Kana, V Mizrahi
Journal of bacteriology 2009
Global health inequity: scientific challenges remain but can be solved
Carol A. Dahl, Tadataka Yamada
Journal of Clinical Investigation 2008
Unfolding the relationship between secreted molecular chaperones and macrophage activation states
B Henderson, S Henderson
Cell stress & chaperones 2008
Interferon-gamma release assay for the diagnosis of latent TB infection--analysis of discordant results, when compared to the tuberculin skin test
A Nienhaus, A Schablon, R Diel
PloS one 2008
High Functional Diversity in Mycobacterium tuberculosis Driven by Genetic Drift and Human Demography
R Hershberg, M Lipatov, PM Small, H Sheffer, S Niemann, S Homolka, JC Roach, K Kremer, DA Petrov, MW Feldman, S Gagneux, MJ Blaser
PLoS Biology 2008

← Previous 1 2 3 4 5 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 policy sources
Referenced in 8 patents
Highlighted by 1 platforms
248 readers on Mendeley
3 readers on CiteULike
See more details